Table 2 Summary of clinical symptoms and laboratory findings of patients with COVID19 reported in the included studies are listed, (total: 154)
From: Immunological effects of convalescent plasma therapy for coronavirus: a scoping review
Clinical symptoms | Number of studies (%) | Laboratory findings | Number of studies (%) |
|---|---|---|---|
Fever | 90 (58.4%) | Lymphopenia | 72 (46.7%) |
Low levels of oxygen O2 | 94 (61%) | Increased CRP/ESR | 98 (63.6%) |
Cough | 74 (48%) | Increased LDH | 41 (26.6%) |
Pneumonia | 49 (31.8%) | Increased IL-6 | 42 (27.2%) |
Dyspnea | 76 (49.3%) | Increased ferritin | 49 (31.8%) |
ARDS | 24 (15.5%) | Increased d-dimer | 46 (29.8%) |
Lung abnormality | 70 (45.4%) | Â | Â |
Chills | 7 (4.5%) | Â | Â |
Diarrhea | 26 (16.8) | Â | Â |
Poor appetite | 6 (3.8%) | Â | Â |
Fatigue | 24 (15.5%) | Â | Â |
Sore throat | 11(7.1%) | Â | Â |
Vomiting and nausea | 18 (11.6%) | Â | Â |
Chest pain | 8 (5.1%) | Â | Â |
Headache | 16 (10.3%) | Â | Â |
Myalgia | 24 (15.5%) | Â | Â |
MODS | 8 (5.1%) | Â | Â |
Anosmia/ageusia | 5 (3.2%) | Â | Â |
General weakness | 6 (3.8%) | Â | Â |
Abdomen pain | 4 (2.5%) | Â | Â |